Clin2
NCT07641725Possibly a fitRecruiting

Light Therapy and Steroid Rinse for Pemphigus Mouth Sores

Oral Lesions in Patients With Pemphigus Vulgaris

Part of Mouth & dental, Skin clinical trials.

This study tests whether a steroid mouthwash and/or light therapy (photobiomodulation) can help heal painful mouth sores caused by pemphigus vulgaris, an autoimmune disease that damages the inside of the mouth and skin.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • Confirmed diagnosis of pemphigus vulgaris (confirmed by skin biopsy and blood tests showing specific antibodies)
  • Active mouth sores at least 1 cm across that are currently open or ulcerated
  • Currently taking a stable dose of oral steroid medication (not more than 1 mg per kg of body weight daily)
  • No uncontrolled diabetes, severe stomach problems, or history of cancer
  • Not pregnant, not breastfeeding, and not taking antibiotics, NSAIDs, or hormonal therapies that could interfere with results

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06971172Not yet recruiting
Low-level laser for mouth sores in pemphigus vulgaris

This trial tests whether low-level laser therapy (a gentle light treatment) can help heal mouth sores caused by pemphigus vulgaris and reduce pain. If you qualify, you may get this non-invasive therapy as part of the study.

NCT06904040Not yet recruiting
Study of CM313 for treating pemphigus

This study tests a new medicine called CM313 for people with moderate to severe pemphigus, a condition that causes painful blisters on the skin and mouth. The goal is to see if CM313 can help reduce these blisters and improve quality of life.

Chengdu
NCT07278999Recruiting
Light therapy and clobetasol for oral lichen planus

This trial tests two light-based treatments (photobiomodulation and photodynamic therapy) and a steroid cream (clobetasol) for painful oral lichen planus. The goal is to see which treatment works best to reduce mouth sores and discomfort.

Zabrze, Silesian Voivodeship
NCT06663943Not yet recruiting· Phase 1/Phase 2
Testing a new antibody drug for moderate to severe pemphigus

This study tests a new drug called CM313 (an antibody that targets a protein on immune cells) for treating pemphigus, a condition that causes painful blisters on the skin and mouth. The goal is to see if it can reduce blisters and improve quality of life, especially for people who haven't responded well to other treatments.

NCT06901427Not yet recruiting
Lifestyle program for pemphigus patients

This trial tests whether a structured lifestyle program (diet and exercise) can improve quality of life for people with pemphigus, a chronic blistering skin condition. If you have pemphigus, this could help you feel better day-to-day.

NCT07769333Not yet recruiting· Early Phase 1
Comparing two drug combinations for moderate-to-severe pemphigus

This study compares two treatments for moderate-to-severe pemphigus vulgaris, a rare skin blistering condition. One group gets rituximab plus corticosteroids, the other gets corticosteroids plus azathioprine. It aims to find which combination works better to control the disease with fewer side effects.

Hear when a new Oral Lesions in Patients With Pemphigus Vulgaris trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.